Please login to the form below

Not currently logged in
Email:
Password:

Digital intelligence blog

Pharma insight on digital marketing, social media, mobile apps, online video, websites and interactive healthcare tools

Medtronic partners with Fitbit for diabetes tracking

Will integrate the health trackers into its CGM mobile app

Fitbit Charge lifestyle 

Medtronic is working with Fitbit to integrate health and activity tracking functions into the new version of its continuous glucose monitoring (CGM) mobile app.

The medical technology firm hopes its iPro2 myLog app will provide a simplified way for patients with type 2 diabetes to manage their condition by presenting their glucose and physical activity levels within a single app.

Medtronic said its tie-up with Fitbit would provide “meaningful insights into how exercise impacts glucose levels for more effective diabetes care management”.

Laura Stoltenberg, general manager of Non-Intensive Diabetes Therapies at Medtronic, said: "[There] has never been more important to increase the collaboration between healthcare and technology to simplify daily diabetes management for the 29 million patients living with type 2 diabetes in the US.

"By creating a connection between physical activity and glucose levels, our iPro2 myLog mobile app solution provides new tools and insights, so that physicians can optimise therapy and patients can better understand how to manage their diabetes.”

The aim is for the new version of the app, which is available for Apple and Android devices, to provide a better understanding of the impact exercise has on glucose levels, and the partners said MyLog would also make it easier for information to be shared with a patient's healthcare team.

Adam Pellegrini, vice president of digital health for Fitbit, said: "We believe the integration of wearable technology with professional diagnostic tools can provide a more accurate and actionable view of a patient's physical activity. 

"By partnering with Medtronic, we are able to bring the power of Fitbit's automatic activity tracking together with continuous glucose monitoring, allowing patients and providers to have a more informed conversation."

Pellegrini recently joined Fitbit from Walgreens Boots Alliance in September, when he was recruited as part of the wellness company's bid to strike more industry partnerships.

The new app is meant to be used in conjunction with Medtronic's iPro2 Professional CGM system, which records a patient's glucose levels 24 hours a day for up to six days.

The iPro2 myLog mobile app displays glucose and sensor data from the iPro2 CGM device and can now integrate physical activity data collected from a patient's Fitbit activity tracker.

The tie-up with Fitbit is Medtronic's latest step to inject new technology into its CGM portfolio, following partnerships with Qualcomm on diabetes sensors and Samsung on diabetes devices.

22nd December 2016

From: Sales

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
M&F Health

M&F Health is a full service communications agency, dedicated to the health and wellbeing sector. We are an independent amongst...

Latest intelligence

World Pancreatic Cancer Day 2018: Combating misconceptions in pancreatic cancer
Patients diagnosed with pancreatic cancer face a dismal prognosis, with the disease having the lowest survival rate of all major cancers. In spite of this, pancreatic cancer research is chronically...
World Diabetes Day: Interaction and impact of diabetes on mental health
For World Diabetes Day on the 14th November 2018, Nisha Shahrukh - Medical Writer at Mednet Group has written an article depicting the impact diabetes has on mental health. Including...
EU
Innovation in merger control and the impact on the pharmaceutical sector
Is focusing on pipeline products enough to assess regulatory risks?...

Infographics